Our team is the backbone of our success. We ensure your projects receive maximum support from a dedicated team of cross-functional experts who are highly skilled at managing process development challenges within the biopharmaceutical sector. Our clients also leverage our technical expertise on Phase appropriate redevelopment programmes to solve challenges in existing projects.

With extensive Phase appropriate support, we offer synthetic route redesign, process optimisation, impurity synthesis and assessment, analytical method development and qualification, full structure characterisation and elucidation, stress studies and ICH stability standards, and CMC gap analysis for commercialisation.

Our facilities are Health Canada and FDA audited with fully-functional synthesis laboratories equipped with advanced instruments. Our state-of-the-art manufacturing suites also offer customisable technology platforms for the synthesis of advanced intermediates and New Chemical Entities (NCEs)/ Active Pharmaceutical Ingredients (APIs).

Significant experience in commercialising FDA designated Fast Track, Breakthrough and Orphan therapeutics, leveraging the experience and resources of the full organisation (development, CMC regulation, manufacturing) to quickly advance programmes from Phase I immediately to commercial launch